Contemporary Management of Postchemotherapy Testis Cancer

Slides:

Advertisements

Similar presentations

Volume 72, Issue 3, Pages (September 2017)

Advertisements

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 70, Issue 4, Pages (October 2016)

Volume 60, Issue 2, Pages (August 2011)

Volume 66, Issue 2, Pages (August 2014)

Volume 71, Issue 3, Pages (March 2017)

Volume 61, Issue 5, Pages (May 2012)

Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique Sevan Stepanian, Mayank Patel, James.

Volume 65, Issue 1, Pages 7-16 (January 2014)

Volume 60, Issue 5, Pages (November 2011)

EAU Guidelines on Testicular Cancer: 2011 Update

Volume 70, Issue 5, Pages (November 2016)

Metastatic Spermatocytic Seminoma – An Extremely Rare Disease

Volume 66, Issue 6, Pages (December 2014)

Ziya Kirkali, Hein Van Poppel European Urology

Let the Games Begin (with EAU Approval)

Volume 71, Issue 5, Pages (May 2017)

Prostate Cancer Epidemic in Sight?

Volume 50, Issue 5, Pages (November 2006)

What is New in Bladder Cancer Diagnosis and Management?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 73, Issue 3, Pages (March 2018)

Volume 67, Issue 2, Pages (February 2015)

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

Volume 73, Issue 2, Pages (February 2018)

Volume 61, Issue 5, Pages (May 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 60, Issue 5, Pages (November 2011)

Volume 64, Issue 3, Pages (September 2013)

Surgery in Metastatic Testicular Cancer

Volume 72, Issue 5, Pages (November 2017)

Prostate Cancer Epidemic in Sight?

Thromboembolic Events Following Surgery for Prostate Cancer

The PSA Era is not Over for Prostate Cancer

Volume 51, Issue 2, Pages (February 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision Hansjörg Keller, Joachim Lehmann, Jörn Beier

Metastatic Spermatocytic Seminoma – An Extremely Rare Disease

The Economic Costs of Overactive Bladder in Germany

Volume 65, Issue 1, Pages 7-16 (January 2014)

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Volume 50, Issue 2, Pages (August 2006)

Testicular Cancer Variations in Time and Space in Europe

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Combined replacement of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal extraosseous osteosarcoma Joseph R. Schneider,

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Volume 75, Issue 4, Pages (April 2019)

Prosthetic replacement of the inferior vena cava for malignancy

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer Stephen D.W. Beck, MD, Stephen.

Improving Flexibility and Quality of Life for Your Patients: A Must?

It’s All in the “Swerve of the Curve”

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

European Urology Oncology

John T. Jerius, MDa, Donald A. Elmajian, MDb, David M

Penile and Testicular Cancer: What's New in 2006?

Primary malignant lymphoma of superior vena cava

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Contemporary Management of Postchemotherapy Testis Cancer Siamak Daneshmand, Peter Albers, Sophie Dorothea Fosså, Axel Heidenreich, Christian Kollmannsberger, Susan Krege, Craig Nichols, Jan Oldenburg, Lori Wood European Urology Volume 62, Issue 5, Pages 867-876 (November 2012) DOI: 10.1016/j.eururo.2012.08.014 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Adjuvant surgery in a patient undergoing postchemotherapy retroperitoneal lymph node dissection: (a) residual retroperitoneal lymphadenopathy involving the vena cava, (b) intraoperative vena cavoscopy showing intraluminal tumor invasion, and (c) postchemotherapy retroperitoneal lymph node dissection with infrarenal vena cava resection without graft placement. European Urology 2012 62, 867-876DOI: (10.1016/j.eururo.2012.08.014) Copyright © 2012 European Association of Urology Terms and Conditions